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Abstract
Purpose: To assess the feasibility of our newly developed cardiovascular magnetic resonance (CMR) methods to 
quantify global and/or regional myocardial oxygen consumption rate (MVO2) at rest and during pharmacologically-
induced vasodilation in normal volunteers.
Methods: A breath-hold T2 quantification method is developed to calculate oxygen extraction fraction (OEF) and 
MVO2 rate at rest and/or during hyperemia, using a two-compartment model. A previously reported T2 quantification 
method using turbo-spin-echo sequence was also applied for comparison. CMR scans were performed in 6 normal 
volunteers. Each imaging session consisted of imaging at rest and during adenosine-induced vasodilation. The new T2 
quantification method was applied to calculate T2 in the coronary sinus (CS), as well as in myocardial tissue. Resting CS 
OEF, representing resting global myocardial OEF, and myocardial OEF during adenosine vasodilation were then 
calculated by the model. Myocardial blood flow (MBF) was also obtained to calculate MVO2, by using a first-pass 
perfusion imaging approach.
Results: The T2 quantification method yielded a hyperemic OEF of 0.37 ± 0.05 and a hyperemic MVO2 of 9.2 ± 2.4 μmol/
g/min. The corresponding resting values were 0.73 ± 0.05 and 5.2 ± 1.7 μmol/g/min respectively, which agreed well 
with published literature values. The MVO2 rose proportionally with rate-pressure product from the rest condition. The 
T2 sensitivity is approximately 95% higher with the new T2 method than turbo-spin-echo method.
Conclusion: The CMR oxygenation method demonstrates the potential for non-invasive estimation of myocardial 
oxygenation, and should be explored in patients with altered myocardial oxygenation.
Introduction
As an aerobic organ, the heart has to consume large
amounts of O2 for its primary contractile function. Oxy-
gen supply and demand must match to maintain normal
myocardial contractility. The myocardial oxygen extrac-
tion fraction (OEF = ([O2]artery  - [O2]venous)/[O2]artery)
reflects this balance in the heart. Non-invasive assess-
ments of this parameter are of paramount interest
because they may provide convenient and cost-effective
tools to study the pathophysiology and metabolic conse-
quences of myocardial ischemia. While progress has been
made in the qualitative assessment of myocardial oxygen-
ation with myocardial T2 or T2* contrast [1-3], limited
effort has been devoted to quantification of myocardial
OEF by cardiovascular magnetic resonance (CMR), par-
ticularly on a regional basis. A quantification model was
recently reported to measure myocardial OEF during
pharmacologically induced hyperemia in vivo using myo-
cardial BOLD effects [4,5]. The model was validated in
animal studies, using a segmented black-blood Turbo-
Spin-Echo (TSE) sequence with T2 contrast. However,
this CMR T2  based oximetry technique has yet been
assessed in human subjects. Furthermore, irregular ECG
triggering due to tachycardia or arrhythmias, and unsatu-
rated blood flow artifacts, which often occur in cardiac
patients, may deteriorate the T2-weighted image quality
using the TSE sequence.
The overall goal of this study was to translate our vali-
dated CMR oximetry technique to human imaging. In
particular, we investigated a modified T2  preparation
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technique (T2prep) that can be performed in human sub-
jects with reduced susceptibility to the adverse ECG-trig-
gering effects aforementioned and improved sensitivity to
myocardial oxygenation alternations. Similar methods
were reported recently to qualitatively assess myocardial
oxygenation [6,7]. Like the quantification model, it uti-
lizes T2-weighted contrasts. However, by selecting proper
imaging parameters, the imaging procedure can be sim-
plified compared to the TSE methods. Moreover, the OEF
at the coronary sinus can be quantified using the T2prep
sequence as an index of global myocardial OEF at rest,
which was an assumed value in the previous animal stud-
ies [4,5]. Lastly, unlike the intravascular contrast agent
used in the previous animal studies, we will utilize an
FDA-approved extracellular agent, Multihance, for myo-
cardial perfusion quantification which is used for the
measurement of myocardial oxygen consumption rate
(MVO2). The CMR T2prep oximetry method was demon-
strated in human volunteers, at rest and during adenos-
ine-induced vasodilation. The findings from the T2prep
method were compared with the previously reported TSE
method for the quantification of myocardial OEF during
adenosine vasodilation.
Theory and Methods
Theory
The detail of the model was reported previously [4].
Briefly speaking, in T2-weighted TSE or spin-echo (SE)
images with an interecho spacing τ (the time difference
between two consecutive 180° pulses in TSE or between
the 90° pulse and subsequent echoes in SE), the signal in a
myocardial tissue voxel can be approximated in a biexpo-
nential form from a two-compartment model as follows:
where Svoxel is the mean signal intensity of the voxel at
echo time TE,; S0 is a variable related to the proton den-
sity of the voxel, receiver gain, and T1 of the tissue. T2b
and T2t are the T2 values of blood and tissue, respectively.
Using the van Zijl intravascular component model [8],
intravascular T2 can be derived:
where α1, α2, and α3 are the functions of magnetic sus-
ceptibilities, interecho spacing τ, oxygenation-dependent
T2 of erythrocytes and plasma, arterial oxygen saturation,
and hematocrit. The three constants can be derived with
experimental data obtained at 1.5 T [9], using subject-
specific hematocrit values. For coronary sinus imaging,
only the first term in Eq. [1] was used. The extravascular
T2t can be approximated using a diffusion model [10,11]:
where R20t is the intrinsic myocardial tissue transverse
relaxation rate, and R21t is a function of the diffusion con-
stant (D), susceptibility difference between the blood ves-
sel and the surrounding tissue, geometry of the heart
relative to the B0 static field, and the size of capillary and
venous vessels. Therefore, both R20t and R21t are subject-
specific parameters and need to be determined during
each imaging session. Increasing τ180 would increase the
sensitivity of this method to the changes of myocardial
oxygenation. With knowledge of R20t, R21t, apparent myo-
cardial T2, and MBV, hyperemic myocardial OEF can be
calculated through Eqs. (1-3).
T2prep Imaging Method for Myocardial OEF Estimation
The T2prep sequence was implemented in a 1.5 T Sie-
mens Sonata system (Siemens Medical Solutions,
Malvern, PA) (Figure 1). The sequence consists of a
T2prep module and gradient-echo acquisition module.
The T2prep module maintains the flexibility of changing
the number of 180° pulses between two 90° tip-down and
tip-up pulses. No gradients were played during the T2
preparation period, except one large spoil gradient at the
end of T2prep module. Both 90° and 180° pulses were
composite pulses. The 90°x consisted of a (270°x)(360°-x)
composite pulse, whereas the 180°x was consisted of a
(90°x)(180°y) (90°x) composite pulse. The last tip-up 90°
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Figure 1 Diagram of T2prep sequence for the measurement of 
myocardial T2-weighted images. The sequence begins with a 
T2prep module followed by a N-line of gradient-echo data acquisition 
using a flip angle of β. All pulses in T2prep module are composite puls-
es. The acquisition continues until the full k-space lines are collected. 
The second TE2 images are then acquired in the same manner, fol-
lowed by the TE3, TE4, etc.
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pulse was (360°x270°-x). If the TE is fixed, more 180°
pulses will lead to less interecho spacing τ. In this study,
because longer τ may increase the sensitivity of the
sequence to the changes in myocardial oxygenation due
to the extravascular diffusion weighting factor [5], it is
desirable to have 180° pulses as less as possible in the
T2prep module. A previous study [12] showed that a 4-
180° scheme can minimize the B1 and B0 inhomogene-
ities. We observed (data not shown) that a T2prep module
with three 180° pulses is sufficient to minimize inhomo-
geneity artifacts. The gradient-echo acquisition allows for
bright-blood imaging, and thus reduces the flow artifacts.
In addition, gradient-echo acquisition is less sensitive to
cardiac motion compared to the TSE sequence.
The T2prep sequence was used to obtain T2 maps with
different TE values. In the previous OEF model using the
TSE acquisition, at least two different τ180 values were
needed to calculate model parameters R20t and R21t, lead-
ing to two separate TSE acquisitions at rest. Using the
T2prep method, only one acquisition is necessary since
different TE or τ180 values are used for the T2 calculation.
Therefore, we developed a multi-variable regression
method for the data set {Svoxel, TE, α1, α2, α3} at rest for
the determination of R20t and R21t. Then using the data set
during hyperemia, a similar multi-variable regression can
be repeated again to calculate the hyperemic OEF. Table 1
shows the TE and the model parameters we used to fit Eq.
(1-3) in this method. The way to derive these parameters
was reported previously [5], which were based on the the-
oretical model by another group [8]. It is noted that these
parameters in Table 1 are different between myocardium
and CS due to the difference in hematocrit value [8]. The
hematocrit was assumed to be one half of that in coro-
nary sinus (40%), i.e. 20% [13]. Increasing τ180  will
increase α1, α2, α3, and thereby increase the sensitivity of
T2 to the change in OEF (Eq. 2 and 3). MBV at rest and
during hyperemia were calculated independently by
using first-pass perfusion imaging.
OEF of Coronary Sinus
We estimated the resting global OEF using a similar
m e t h o d  r e p o r t e d  b y  F o l t z  e t  a l  [ 1 4 ] .  B r i e f l y ,  c o r o n a r y
sinus T2 was measured using the same T2prep imaging
sequence. The resting OEF was determined by a blood
T2-OEF model, expressed in Eq. [1-2] with the parame-
ters defined in Table 1. Since 90% of left interventricle
blood is drained to the coronary sinus, such measured
resting OEF should represent the global OEF of the left
ventricle.
T2 Phantom Study
The T2 accuracy measured by the T2prep sequence was
first studied in a phantom study. Four polyethylene tubes
with a diameter of 3 cm were filled by a combination of
agarose, Gd-DTPA, and NaCl, and distilled water. Such
compositions created phantoms with T1, T2, and dielec-
tric property similar to human myocardial tissues [15].
The concentrations of these components were slightly
varied to yield T2 from 30 to 50 msec in 4 phantoms.
Table 2 lists the T1 and T2 values of these phantoms. The
T2prep sequence using the same imaging parameters as
in volunteer study (see below) was applied to scan these
phantoms. Standard spin echo sequence with 7 different
TEs from 24 to 96 msec was used to provide reference T2
values.
Volunteer Study
Six healthy volunteers (average age = 32 ± 5 years old, 4
male) were recruited for this study. Informed consent was
obtained from each volunteer prior to imaging session.
Figure 2 shows the time sequence of the measurements.
Coronary sinus imaging was performed first at rest, fol-
lowed by T2-weighted imaging using both T2prep and
TSE sequences. The location of the image plane was
approximately 2-3 cm from the sinus ostium [14] to
ensure the blood in the CS was dominated by the venous
blood. We selected Multihance as the contrast agent for
the first-pass perfusion imaging, partially because of its
lowest risk profile to nephrogenic systemic fibrosis (NSF)
Table 1: Fitting Parameters for the Calculation of Coronary Sinus and Myocardial Hyperemic OEF
TE (ms) Coronary Sinus Myocardium
α1 α2 α3 α1 α2 α3
24 2.42 4.25 3.94 2.52 2.69 2.83
36 4.78 5.27 4.05 3.76 3.22 2.89
48 7.25 6.33 4.17 4.57 3.57 2.93
60 9.55 7.32 4.28 5.09 3.80 2.95
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[16]. Bolus injections of Multihance (0.02 mmol/kg) were
performed two times using a MR compatible injector
(Spectris, Medrad, Indianola, PA), once at rest and once
4-6 min after the start of infusion of adenosine for coro-
nary artery vasodilation. The time interval between two
contrast injections was 15 ± 2 min. This allowed for the
washout of the first contrast agent to minimize the inter-
ference of two contrast injections.
Adenosine was infused intravenously for 6 minutes at a
constant rate of 0.14 mg/kg/min by using a CMR compat-
ible infusion system (Continuum, Medrad, Indianola,
PA). Two minutes after the start of adenosine infusion,
CMR started with T2-weighted imaging, followed by the
first-pass perfusion imaging as the last scan. Heart rate
(HR) and blood pressure (BP) were measured continu-
ously during the entire image session with an CMR-com-
patible vital-signs monitoring system (Millennia; Invivo
Research, Orlando, FL). The hard record was obtained at
rest and every 1 min after the start of the adenosine infu-
sion until the end of the infusion.
The T2-weighted imaging consisted of two imaging
methods: T2prep and TSE. The image parameters for
T2prep were as follows: TE in the T2prep module = 24,
36, 48, 60, 72 ms, gradient-echo readout TR/TE = 3.6/2.0
ms, segmentation number = 27-35 (depending on the RR
interval), bandwidth = 400 Hz/pixel, slice thickness = 8
mm, data matrix = 145 × 256, FOV = 255 × 340 mm2, and
flip-angle = 15°. The scan time was approximately 20-25
sec. For CS imaging, the spatial resolution was slightly
higher, i.e., data matrix = 162 × 256, resulting in a resolu-
tion of 1.57 mm × 1.32 mm. For TSE imaging at rest, two
scans were performed using two different interecho spac-
ing τ values, i.e., 8 and 12 ms, to calculate parameters R20t
and R21t in Eq. [3]. Other imaging parameters included:
TE = 24, 48, and 72 ms, segmentation number = 5, band-
width = 390 Hz/pixel, slice thickness = 8 mm, data matrix
= 145 × 256, FOV = 255 × 340 mm2, scan time = 22-25
sec. Respiratory motion was controlled by breath-hold at
end-expiration.
The first-pass perfusion sequence was a 2 D multi-slice
saturation-recovery (SR) prepared Turbo FLASH
sequence with a total of 70-80 images acquired in each
slice. The T1-weighting was provided by a volume-selec-
tive SR pulse. Each dynamic image was obtained in mid-
diastole by ECG triggering. The center slice was located
approximately at the mid-cavity level of the left ventricle
across the papillary muscles in a short-axis view. Image
parameters were as follows: TR/TE = 2.4/1.2 ms, slice
thickness = 8 mm, data matrix = 84 × 256, FOV = 137 ×
220 mm2, flip-angle = 18°, and SR time = 100 ms depend-
ing on the RR interval. Respiratory motion was controlled
by breath-hold at the end expiration.
Image Processing and Statistical Analysis
The central slice of the perfusion imaging corresponding
to the T2prep slice was processed using homemade soft-
ware developed in our laboratory, written in JAVA (Java
V5.0, Sun Microsystems, Santa Clara, CA). A model-free
deconvolution method, Consolidated-basis, was imple-
mented to calculate MBF and MBV [17]. The approach
used a linear combination of basis functions to represent
impulse function. Few parameters [3] are required for the
deconvolution process and thus noise-sensitivity is rela-
tively low. Using the mean transit time (MTT) deter-
mined by the software, MBV is calculated as the product
of MTT and MBF. The software provides the capability
for denoising the image before mapping MBF or MBV
[18]. On each MBF map, a large, global ring ROI was
drawn to include approximately 75% transmural left ven-
tricle myocardial wall to calculate the global MBF. Input
curves for these calculations were obtained from a circu-
lar ROI manually drawn over the left ventricle blood pool.
To process coronary sinus images, a circle ROI was
drawn in the center of the coronary sinus and adjusted
manually for the compensation of motions between dif-
ferent T2-weighted images. These signal intensities were
then fitted to Eq. (1-2) using the constants defined in
Table 1, without using the second term in Eq. (1). Resting
Table 2: T2 phantoms and T2 measurement results with T2prep and SE sequences
Sequences Phantom 1
(1043.5)
Phantom 2
(1122.4)
Phantom 3
(754.3)
Phantom 4
(859.5)
SE 32.3 43.9 46.5 51.4
T2prep 32.3 43.5 46 51.7
Errors (%) 0 -0.91 -1.0 0.6
T1 values are shown in parenthesis.
Figure 2 Time sequence of human study protocol.McCommis et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:34
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CS OEF could be obtained by the multi-variable regres-
sion method using DataFit (Oakdale Engineering,
Oakdale, PA).
Myocardial T2prep images were analyzed by drawing
the same ring ROI as in the perfusion measurements and
T2-weighted signal intensities at rest and during stress
w e r e  o b t a i n e d  a t  d i f f e r e n t  T E s .  T h e o r e t i c a l l y ,  R 20t and
R21t can be determined using Eqs. (1-3) by using multi-
variable non-linear regression procedures. However, it
was found that non-linear fitting was not stable due to
few data points for 3 parameters to be calculated. We
have thus developed following procedures to calculate
these parameters and myocardial regional OEF during
stress:
(a) Using a single-variable non-linear regression, appar-
ent T2apparent  values are calculated at rest and during
stress;
(b) With OEF obtained at rest from the CS measure-
ment, R2b can be calculated at each TE using Eq. [2]; and
R2t  can be then calculated using Eq. [1] with MBV
obtained from the perfusion measurement at rest.
(c) In Eq. [3], R2t is linearly correlated with R20t and R21t
with the single variable OEF2MBV2τ2, where τ = TE/3. By
linear fitting of Eq. [3], R20t (the intercept) and R21t (slope)
can be calculated.
(d) With the knowledge of R20t, R21t, and MBV during
stress, the relationship of T2apparent and OEF during stress
can be derived using Eq. (1). Based on T2apparent during
stress from (a), myocardial OEF during stress was
obtained. The procedures for calculating hyperemic myo-
cardial OEF using the TSE method were reported previ-
ously [2]. MVO2 was calculated using the formula: MVO2
(μmol/g/min) = 1.39 (mL O2/(hemoglobin) g) × 0.14
(hemoglobin) g/mL blood × 44.658 (μmol/mL) × 0.95
(Oxygen saturation in arterial blood) × OEF × MBF (mL/
g/min). It should be noted, in contrast to the first-pass
perfusion images, neither OEF nor MVO2 were calcu-
lated from maps, but from ROIs drawn on the source
images.
To compare the performance of T2prep and TSE meth-
ods, T2 sensitivity was defined as
It indicates the percentage change in measured myo-
cardial T2  per 100% increases in MBF. All data are
expressed as mean ± SD. Paired student's T-tests were
performed to test significant differences between the TSE
and T2prep methods, as well as between resting and
hyperemic parameters. P < 0.05 was considered statisti-
cally significant.
Results
Phantom Study
The T2 measurement results are shown in Table 2 and the
T2 error by using T2prep sequence was less than 1% in
comparison with reference T2 values.
MBF, OEF, and MVO2 of Global Myocardium at Rest
The volunteer's hemodynamic data along the time course
is presented in Table 3, along with the measurement
results of OEF of the coronary sinus at rest. HR and rate
pressure product (RPP) were both significantly elevated
over the resting values during adenosine infusion (~70%
increase in RPP). Systolic blood pressure showed signifi-
cant elevation only at 1 and 5 min after the start of ade-
nosine infusion. The increase in RPP with the
vasodilation agent adenosine is not unusual as this was
also reported by others [19,20]. Figure 2 shows examples
of T2-weighted images of the coronary sinus of one vol-
unteer using the T2prep sequence. The resting CS T2 was
62 ± 4 msec and OEF was 0.73 ± 0.05, which agrees nicely
with one previously reported global OEF of healthy vol-
unteers (0.71 ± 0.08) measured by PET imaging [21]. The
mean resting global MBF was 0.89 ± 0.36 mL/g/min and
MBV was 5.5 ± 1.8 mL/100 g tissue. The corresponding
resting MVO2 is approximately 5.2 ± 1.7 μmol/g/min or
0.116 ± 0.038 mL/g/min which also agrees well with pub-
lished data in normal humans [18,22].
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Table 3: Hemodynamic Data of the Volunteers and Resting CS OEF
Heart Rate Systolic Pressure Rate-Pressure Product Resting OEF
Rest 72 ± 11 113 ± 6 8102 ± 1273 0.73 ± 0.03
Adenosine 110 ± 16† 120 ± 13 13878 ± 1201†
Values are presented as mean ± SD
†P < 0.001 for the comparison between rest and adenosine
(4)McCommis et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:34
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MBF, OEF, and MVO2 of Global Myocardium during 
Adenosine Stress
One set of hyperemic BOLD images with the TSE
method was distorted in one volunteer due to rapid
changes in heart rate during adenosine infusion, but
T2prep scans were completed in all volunteers. Figure 3
demonstrates three T2-weighted images using T2prep
sequence and one distorted TSE images during the ade-
nosine infusion. Table 4 shows the comparison of myo-
cardial perfusion and oxygenation parameters from both
the TSE and T2prep methods. Except for MVO2 obtained
by the TSE method, significant differences were found
between adenosine and resting measurements for all
other parameters.
The mean hyperemic MBF was 2.97 ± 0.75 mL/g/min
and MBV was 9.9 ± 2.4 mL/100 g. Adenosine induced 220
± 152% increase in MBF and 65 ± 53% increase in MBV.
The corresponding global myocardial T2 changes were
5.8 ± 2.0 % with the TSE method and 11.5 ± 8.1% with the
T2prep method. Global myocardial T2 values are gener-
ally lower with T2prep method than TSE, due to the dif-
fusion effects with larger echo spacing time in the T2
preparation pulses (8). The T2 sensitivity is approxi-
mately 95% higher with the T2prep method than TSE
method, although no significant difference was observed
due to limited subject number. The R20t, representing
intrinsic myocardial tissue R2, was 24.5 ± 4.1 sec-1. The
R21t, reflecting geometry of the heart and local gradient
fields, was 10.6 ± 9.7 (×104) sec-3. For the T2prep
method, myocardial OEF was reduced 47 ± 21% during
adenosine infusion and mean MVO2 increased approxi-
mately 88 ± 75%. This magnitude increase is consistent
with the increase in the RPP value (71%). Overall, there
were no significant differences in OEF and MVO2 mea-
surements between the T2prep and TSE methods.
Discussion
A modified quantitative CMR method was demonstrated
to estimate global myocardial OEF and MVO2 in humans,
at rest and during pharmacologically induced vasodila-
tion. While resting OEF and MVO2 are only measurable
on coronary sinus, regional myocardial OEF and MVO2
can be measured during hyperemia using myocardial
BOLD effects. Adenosine induced 2-3 fold increases in
MBF that exceeded the increase in MVO2. Consequently,
myocardial OEF was reduced 47% in normal volunteers.
The bright-blood T2prep method appears to be a better
method than black-blood TSE technique, as indicated in
much improved T2 sensitivity to the changes in myocar-
dial blood flow (Table 4).
The models to estimate hyperemic myocardial OEF and
MVO2 were established and validated in animal studies
previously, using a black-blood TSE sequence [4,5]. How-
ever, in some cases, particularly in the presence of tachy-
cardia or arrhythmias, black-blood preparation using the
double inversion technique does not sufficiently suppress
the blood signals in the left ventricle, resulting in flow
artifacts on the myocardium. This often leads to
decreased myocardial T2 and thus overestimation of myo-
cardial OEF. The bright-blood T2prep technique, fol-
lowed by robust gradient-echo acquisition, avoids these
flow artifacts. Unlike the procedure to estimate hypere-
mic OEF using the TSE sequence [4,5], in which two rest-
ing scans are required to estimate model parameters R20t
and R21t, the use of the T2prep sequence requires only one
resting scan for this purpose. Up to five images with dif-
f e r e n t  e c h o  t i m e s  ( T E s )  c a n  b e  a c q u i r e d  w i t h i n  o n e
breath-hold rather than only 3 images using the TSE
sequence, potentially increasing the precision of the OEF
estimation. With the use of larger 180° echo time (τ), the
Table 4: Global Myocardial Perfusion and Oxygenation in Volunteers (Data is presented as mean (SD))
Method T2 MBF
(mL/g/min)
MBV
(mL/g)
OEF MVO2
(μmol/g/min)
T2sen*
T2prep Rest 44 (6) 0.89 (0.36) 0.06 (0.02) 0.73 (0.05) 5.2 (1.7)
Aden 49 (5)† 2.97 (0.75)† 0.10 (0.02)† 0.37 (0.05)† 9.2 (2.4) ξ 4.8(5.1)
TSE Rest 55 (4)†† 0.73 (0.05) 5.2 (1.7)
Aden 59 (4) † 0.41(0.14)† 10.4 (5.1) 3.2(2.9)
OEF at rest are values of coronary sinus in Table 2
MBF and MBV were calculated from the first-pass perfusion imaging data sets.
*T2sen or T2 sensitivity = percentage of T2 change/100% increase in MBF
Aden = Adenosine vasodilation
†P < 0.01 for comparison between rest and adenosine.
ξ P < 0.05 for comparison between rest and adenosine.
††P < 0.05 for comparison between T2prep and TSE methods.McCommis et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:34
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sensitivity of the T2prep method to the changes of MBF
seems to be improved. Finally, the simple adjustment of
segmentation number for the gradient-echo acquisition
allows for the change in breath-holding time, which is
very beneficial for scanning patients in a clinical setting.
While the T2 preparation method to measure myocar-
dial and coronary sinus T2 is not a new approach [13,23],
the sequence developed allowed one T2 mapping with
single breath-hold using up to 5 different TE. This
approach is different from reported methods that used 2
to 3 TEs and/or scan for a relatively long time (~8 min).
Another difference is the gradient-echo readout in the
sequence, in comparison with reported readout
sequences using spiral or TrueFISP. Apparently, gradient-
echo has relatively lower SNR than the other two meth-
ods, but it offers the most robust signal acquisition
against cardiac motion. Spiral readout was not available
in our scanner. TrueFISP readout was not adopted due to
following reasons: a) unlike the gradient echo sequence,
data acquisition of TrueFISP readout starts at approxi-
mately 50 msec after the last 90° pulse in the T2 prepara-
tion module. This time delay reduced the efficiency of T2
weighting; b) steady-state TrueFISP signal is T2/T1
weighting. Because our model to calculate myocardial or
CS OEF relies on T2 measurement, the impact of this T2/
T1 weighting remains to be determined for the accuracy
of OEF measurements. Nevertheless, TrueFISP type of
readout is still an attractive option owing to its higher
SNR. Further investigation of this sequence for the quan-
tification of myocardial OEF is warranted.
Measurement of coronary venous oxygenation was pre-
viously reported by Foltz et al [13] and Y ang et al [24]
using a similar T2prep (MLEV module) with a spiral read-
out data acquisition. Four 180° pulses were used within
the T2prep module to minimize B0 and B1 inhomogene-
ities in a previous study [12]. The coronary sinus oxygen
content in %-O2 was calculated through an in vitro cali-
bration procedure involving venipuncture and ex vivo
CMR T2 determination in the blood samples. We have
simplified this procedure using a previously established
quantification model and directly calculated oxygen con-
t e n t  o f  c o r o n a ry  s i n u s  i n  O E F  t e r m  b y  a c q u is i t i o n s  o f
multiple T2-weighted signals and nonlinear fitting to the
model equation. The resulted resting OEF appears to be
consistent with other literature values [18]. It is noted
that we used one or three 180° pulses in the T2prep mod-
ule, aiming to maximize the diffusion sensitivity of the
sequence to the changes in blood oxygenation. To effec-
tively minimize B0 and B1 inhomogeneity, the combina-
tion of MLEV-4 pattern and composite pulses in the
T2prep module may still be the optimal condition [12].
Our sequence can be prescribed to using 4 180° pulses in
the T2prep module for a MLEV-4 pattern. However, our
initial exams in six volunteers found similar image quality
using either 3 or 4 180° pulses. Further optimization of
the sequence is necessary to minimize B0 and B1 inhomo-
geneity while maximizing the sensitivity to oxygenation
changes in the coronary system in more subjects. This
will involve using different number of 180° pulses (even
and odd numbers) with the same vasodilation condition
in the same subject. Animal study will likely be ideal for
such optimization purposes.
Rather than using a blood pool contrast agent (not
approved in human study) as in our previously reported
animal study [16], the FDA-approved extracellular agent
Multihance was used in this human study to quantifying
MBF and MBV, using a fast quantification method, a
Consolidated-basis deconvolution. Comparing with the
commonly used Fermi deconvolution, the Consolidated-
basis deconvolution is more versatile and less sensitive to
noise. This is because the Fermi method forces the
impulse response to have an idealized shape - for example
it is always monotonically decreasing, and positive. The
Consolidated-basis does not have this guarantee. Multi-
hance was selected in our human study because of its rel-
atively high T1 relaxivity of 9.7 mM-1sec-1. The increased
Figure 3 Examples of bright blood T2-weighted myocardial images at three different TEs, obtained from a volunteer during the adenosine 
infusion. In comparison, the TSE images collected is distorted by the fast heart rate and flow artifacts, which is not useful for further analysis.McCommis et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:34
http://www.jcmr-online.com/content/12/1/34
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relaxivity derives from weak and transient interactions of
the Multihance chelate with serum albumin. It appears
that such transient interactions may confer a partial
blood pool effect which serves to reduce the rate of con-
trast extravasations compared to other gadolinium based
extracellular agents [25]. In the current human study,
both resting and hyperemic MBF agrees well with other
literature values.
Limitations of this study
In this initial study, the primary goal was to investigate
whether the T2prep method could yield similar hypere-
mic global myocardial OEF and MVO2  as the TSE
method. Regional variations of these parameters were not
assessed because neither OEF nor MVO2 map was cre-
ated. However, such spatial variability needs to be mea-
sured in order for clinical evaluation of ischemic hearts.
Precision and accuracy of this new cardiac oxygenation
method using the T2prep technique have yet to be deter-
mined. A large sample of subjects with repeated measure-
ments may be needed to estimate the precision, in
combination with the noise propagation analysis. How-
ever, accuracy of the measurement has to be determined
in animal studies to compare with the measurement
results with a gold standard, such as blood oxygen con-
tent through arterial and venous blood sampling. A sys-
temic hematocrit of 40% was assumed in this study and
capillary hematocrit was also assumed to be 50% of coro-
nary sinus. Because the parameters in Table 1 depend on
the hematocrit, a small error in the calculation of myo-
cardial OEF during the hyperemia may be introduced. If
the capillary hematocrit varies by 25%, however, the cal-
culated OEF variation is less than 3%. Another limitation
of this method is the lack of regional myocardial oxygen-
ation at rest. This is partially due to the fact that this
method relies on endogenous deoxyhemoglobin, and its
perturbation effects on the field inhomogeneity against
the baseline condition (the so called BOLD effect). Other
methods using exogenous agents, such as 17O-labelled
gas [26] or contrast agents, may have the potential to
resolve this problem. Lastly, CS measurement was not
performed during the adenosine session due to limited
vasodilation effect time (~4 min). Future study without
using TSE sequence can allow estimation of CS oxygen-
ation during the vasodilation.
Conclusion
A modified CMR approach to estimate global myocardial
oxygenation, in terms of myocardial OEF and MVO2, was
designed and examined in human volunteers. The
method has potential to assess regional myocardial OEF
and MVO2  during hyperemia as well. The calculated
global OEF and MVO2 appear to be consistent with other
reported data. This method may be potentially useful for
the assessment and management of patients with regional
myocardial ischemia, as well as patients with altered
global myocardial oxygenation, such as diabetes and obe-
sity.
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